Maizel Ari
SEC CIK 2042289 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | Chief Commercial Off | 7,500 | — | $2.75M | 4 | 2026-01-21 | 2026-04-22 |
Most active insiders at AXSM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TABUTEAU HERRIOT | CEO, Dir, 10% | — | $103.22M |
| 2 | Pizzie Nick | CFO | — | $10.18M |
| 3 | Jacobson Mark L. | COO | — | $8.90M |
| 4 | Coleman Mark | Dir | — | $8.21M |
| 5 | Saad Mark E | Dir | — | $6.21M |
| 6 | Maizel Ari | Chief Commercial Off | — | $2.75M |
| 7 | Mahony Susan | Dir | — | $145.0K |
| 8 | JEFFS ROGER | Dir | — | $141.7K |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-23 21:01 | 2026-04-22 | AXSM | Axsome Therapeutics, Inc. | Maizel Ari | Chief Commercial Off | M - OptEx | $70.73 | +7,500 | 7,500 | New | +$530.5K |
| DT | 2026-04-23 21:01 | 2026-04-22 | AXSM | Axsome Therapeutics, Inc. | Maizel Ari | Chief Commercial Off | S - Sale+OE | $182.42 | -7,500 | 0 | -100% | -$1.37M |
| DT | 2026-01-23 | 2026-01-21 | AXSM | Axsome Therapeutics, Inc. | Maizel Ari | Chief Commercial Off | S - Sale+OE | $184.44 | -7,500 | 0 | -100% | -$1.38M |
| DT | 2026-01-23 | 2026-01-21 | AXSM | Axsome Therapeutics, Inc. | Maizel Ari | Chief Commercial Off | M - OptEx | $70.73 | +7,500 | 7,500 | New | +$530.5K |
Purchase Sale Sale after option exercise All abbreviations